{"id":"22da73b7-c7eb-4a01-b246-146e4f248acc","kind":"news","code":"22da73b7-c7eb-4a01-b246-146e4f248acc","name":"Superluminal Medicines raises USD 60 million in Series B financing","nameBasis":"translated-title","summary":"On 2026-09-03, according to Xiniu Data, Superluminal Medicines completed Series B financing, raising USD 60 million. Investors were lead investor BVF Partners, RA Capital Management, Perceptive Advisors, NVIDIA and others. The company is a provider of U.S. AI generation drugs services.","description":"","country":null,"category":null,"originalName":"Superluminal Medicines完成B轮融资，融资金额6000万美元","eventDate":"2026-09-03T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-19T05:58:25.739Z","englishUpdatedAt":"2026-10-20T18:23:32.195Z","reviewedAt":"2026-10-20T18:23:32.195Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"e855f6ed4c8afe90a744d7fa6a82c59dbeb7896281495ec546d54122add1f4ef","companyId":"7c66c728-c0c9-4716-992b-f0a5fc8d890e","foundedYear":null,"logoUrl":null,"originalText":"2026年9月3日，据烯牛数据报道，Superluminal Medicines完成B轮融资，金额6000万美元。投资方为BVF Partners领投，RA Capital Management，Perceptive Advisors，NVIDIA等。该公司为美国AI生成药物服务商。","sources":[],"related":[{"id":"5f0994d5-b33f-471e-8472-472a85be2a69","kind":"institutions","code":"UB-I7475","name":"BVF Partners","nameBasis":"original-brand","summary":"BVF Partners, a growth equity investment firm.","description":"BVF Partners, a growth equity investment firm.","country":"United States","category":null,"originalName":"BVF Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T10:00:45.012Z","englishUpdatedAt":"2026-10-20T18:26:56.353Z","reviewedAt":"2026-10-20T18:26:56.353Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"2f905bc001c0454eafe0bee231be98b05778fbc31011118f6e5a85d0a35c494c","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/bvf-partners"},{"id":"95d6af86-e104-4512-be32-a32ef1a9ac68","kind":"institutions","code":"UB-I145","name":"Catalio Capital Management","nameBasis":"original-brand","summary":"An investment firm focused on life sciences and healthcare.","description":"An investment firm focused on life sciences and healthcare.","country":"United States","category":null,"originalName":"Catalio Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:12.221Z","englishUpdatedAt":"2026-10-20T18:26:57.140Z","reviewedAt":"2026-10-20T18:26:57.140Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"c663887b7d2eaa4e116b7886e7ec7032049bd046ce719221fb597de02126829f","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/catalio-capital-management"},{"id":"479a9c91-684c-48df-b111-80fcf5f8783a","kind":"institutions","code":"UB-I541","name":"Cooley","nameBasis":"original-brand","summary":"Investment affiliated with Cooley law firm.","description":"Investment affiliated with Cooley law firm.","country":"United States","category":null,"originalName":"Cooley","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:18.430Z","englishUpdatedAt":"2026-10-20T18:26:50.053Z","reviewedAt":"2026-10-20T18:26:50.053Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"36cb37b0104be5c543e576ed2561cc2f281d8828134208933d316d58016a7eff","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/cooley"},{"id":"14a06fcf-b5ca-49e4-9788-429c0331d5c9","kind":"institutions","code":"UB-I7418","name":"Deep Track Capital","nameBasis":"original-brand","summary":"Deep Track Capital is a U.S. early-stage venture capital firm.","description":"Deep Track Capital is a U.S. early-stage venture capital firm.","country":"United States","category":null,"originalName":"Deep Track Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T10:00:43.906Z","englishUpdatedAt":"2026-10-20T18:26:49.330Z","reviewedAt":"2026-10-20T18:26:49.330Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"15e1c98bfa4071010ded4aa5621696e51f01f2c84f45a9a2e943686faf409c68","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/deep-track-capital"},{"id":"c4d6bbd2-be93-4c8c-b3f8-670870244af3","kind":"institutions","code":"UB-I5537","name":"Eli Lilly","nameBasis":"original-brand","summary":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","description":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","country":"United States","category":null,"originalName":"Eli Lilly","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T02:00:22.634Z","englishUpdatedAt":"2026-10-20T18:27:03.531Z","reviewedAt":"2026-10-20T18:27:03.531Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"81b80355fbc0e9ad365438564f2dc16dddd39dc89cffbf807262cf8a6affa1d3","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/eli-lilly"},{"id":"3409c90e-a603-48b3-b175-6b6608175f4e","kind":"institutions","code":"UB-I838","name":"Gaingels","nameBasis":"original-brand","summary":"A well-known US angel co-investment syndicate network.","description":"A well-known US angel co-investment syndicate network.","country":"United States","category":null,"originalName":"Gaingels","eventDate":null,"website":"https://www.gaingels.com/","sourceUpdatedAt":"2026-10-20T07:00:17.633Z","englishUpdatedAt":"2026-10-20T18:26:49.758Z","reviewedAt":"2026-10-20T18:26:49.758Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"e7065bcb2d0dc5bbff35bf41da8d82a3b19edce040c045f0b131d4d653f26571","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/gaingels"},{"id":"10eab593-16d3-4f37-ae9c-64d51d8a9475","kind":"institutions","code":"UB-I043","name":"Insight Partners","nameBasis":"original-brand","summary":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","description":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","country":"United States","category":null,"originalName":"Insight Partners","eventDate":null,"website":"https://insightpartners.com/","sourceUpdatedAt":"2026-10-18T22:00:13.209Z","englishUpdatedAt":"2026-10-20T18:26:49.293Z","reviewedAt":"2026-10-20T18:26:49.293Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"783bc5d18c9f787c77054d4973b5ac60a1232ecd23c03f22c7be93aec7e85960","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/insight-partners"},{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":"United States","category":null,"originalName":"NVIDIA","eventDate":null,"website":"https://www.nvidia.com/","sourceUpdatedAt":"2026-10-20T17:00:11.935Z","englishUpdatedAt":"2026-10-20T18:27:03.389Z","reviewedAt":"2026-10-20T18:27:03.389Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"e8677d0b441a42e930c15aa85b4c132b1dfeda4d489cf27951b3801c5aec760b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"},{"id":"214cbe99-b127-4a38-8e04-68dbf2b156eb","kind":"institutions","code":"UB-I7521","name":"Perceptive Advisors","nameBasis":"original-brand","summary":"Perceptive Advisors, a US healthcare hedge fund and growth investment firm.","description":"Perceptive Advisors, a US healthcare hedge fund and growth investment firm.","country":"United States","category":null,"originalName":"Perceptive Advisors","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T10:00:45.929Z","englishUpdatedAt":"2026-10-20T18:26:49.521Z","reviewedAt":"2026-10-20T18:26:49.521Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"c962e9729952306161688d2b1c9189de776aff3a90a7bbdc4cf6877532557c4c","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/perceptive-advisors"},{"id":"84cacc56-8b65-4ff8-a7ba-456e915dddae","kind":"institutions","code":"UB-I3822","name":"RA Capital Management","nameBasis":"original-brand","summary":"Investment firm focused on biotechnology and healthcare.","description":"Investment firm focused on biotechnology and healthcare.","country":"United States","category":null,"originalName":"RA Capital Management","eventDate":null,"website":"https://www.racap.com/","sourceUpdatedAt":"2026-10-19T04:00:18.517Z","englishUpdatedAt":"2026-10-20T18:26:56.913Z","reviewedAt":"2026-10-20T18:26:56.913Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"9e7d21ed029b3d923176b373985bf05153f6a790d7e5eeb1c89f3d9cbadba909","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ra-capital-management"},{"id":"7c66c728-c0c9-4716-992b-f0a5fc8d890e","kind":"companies","code":"UB-C7640","name":"Superluminal Medicines","nameBasis":"source-english","summary":"","description":"","country":"United States","category":null,"originalName":"Superluminal Medicines","eventDate":null,"website":"https://www.superluminalrx.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:25:20.276Z","reviewedAt":"2026-10-20T18:25:20.276Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"c5be043b006c7116865908fb9e7336ce985636905730df1606955fde81977650","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/superluminal-medicines"}],"path":"/news/22da73b7-c7eb-4a01-b246-146e4f248acc","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Superluminal Medicines","path":"/companies/superluminal-medicines"}},"canonical":"https://uniquebase.ai/news/22da73b7-c7eb-4a01-b246-146e4f248acc"}